通过炎症途径和表观遗传修饰来探索富蒙尼辛B1的心脏毒性潜力:一个小小的综述
Selwyn Kyle Gounder1, Anil Amichund Chuturgoon1, Terisha Ghazi1
1Discipline of Medical Biochemistry, School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban, 4041, South Africa.
概括
富蒙尼辛B1 (FB1) 是一种真菌毒素,通过破坏脂代谢和增加炎症来损害心脏健康. 它还会导致表观遗传变化,使心血管疾病恶化,强调需要进一步研究.
科学领域:
- 毒理学 毒理学 毒理学
- 心血管科学 心血管科学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 富蒙尼辛B1 (FB1) 是一种来自Fusarium真菌的真菌毒素,会污染食品,造成健康风险.
- 它在引起和恶化心血管疾病方面的特定作用需要进一步阐明.
- FB1影响脂代谢,炎症和表观遗传调节.
研究的目的:
- 审查FB1的心脏毒性作用.
- 探索FB1对脂代谢,炎症和表观遗传学的影响.
- 要突出研究FB1相关心脏毒性的需要.
主要方法:
- 对FB1和心脏毒性研究的文献综述.
- 分析FB1对脂体代谢 (胺合成酶抑制) 的影响.
- 检查FB1对炎症标志物 (IL-6,IL-1β) 和表观遗传修饰 (DNA甲基化,基因质修饰,microRNA表达) 的影响.
主要成果:
- FB1抑制了胺合成酶,破坏了脂代谢,导致细胞功能障碍.
- FB1增加了促炎性细胞因子,导致高血压和心力衰竭.
- FB1诱导表观遗传变化,包括DNA高甲基化和改变的基因组标记,影响基因表达和疾病进展.
结论:
- FB1通过破坏脂代谢,炎症和表观遗传变化产生心脏毒性作用.
- 这些机制有助于高血压,心力衰竭和心血管疾病的进展.
- 为了更好地管理风险,进一步的研究至关重要,以了解FB1,炎症,表观遗传学和心脏毒性之间的复杂联系.
相关概念视频
Mutagenicity and Carcinogenicity
1.1K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.1K
NF-κB-dependent Signaling Pathway
7.2K
The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The...
NF-κB-dependent Signaling Mechanism
The...
7.2K
Epigenetic Regulation
2.9K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
2.9K
Teratogenicity
2.3K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
2.3K
Interactions Between Signaling Pathways
6.1K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.1K
Toxic Reactions: Overview
897
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
897


